Pathology of Acute Hepatitis A in Human: Comparison with Acute Hepatitis B

1984 ◽  
Vol 81 (2) ◽  
pp. 162-169 ◽  
Author(s):  
Tadao Okuno ◽  
Atsushi Sano ◽  
Takeshi Deguchi ◽  
Yoshinori Katsuma ◽  
Takeshi Ogasawara ◽  
...  
1991 ◽  
Vol 106 (2) ◽  
pp. 397-402 ◽  
Author(s):  
A. A. Papachristou ◽  
A. S. Dumas ◽  
V. C. Katsouyannopoulos

SUMMARYSerological markers and peak serum alanine aminotransferase (ALT) values of 140 in-patients with acute hepatitis, either type A (n= 90), or type B (n= 50) were prospectively assessed. In 23 out of the 90 patients with acute hepatitis A, evidence of previous experience with hepatitis B virus (HBV) was found, whereas 35 out of the 50 patients with acute hepatitis B had past contact with hepatitis A virus (HAV). The mean peak ALT values [S.D.] were significantly higher in hepatitis A patients with previous experience with HBV (1413 [704] i.u./l), when compared to those without such experience (842 [464] i.u./l, P < 0·001). Such a difference was not evident between acute hepatitis B patients, whether or not they had previous contact with HAV. We conclude that when acute hepatitis A is superimposed on past HBV infection an augmented transaminaemia, indicative of enhanced liver cell necrosis, takes place although a definite explanation is lacking. We suggest that individuals with markers of HBV infection should be early candidates for HAV immunization.


2016 ◽  
Vol 10 ◽  
Author(s):  
Elena Garlatti Costa ◽  
Michela Ghersetti ◽  
Silvia Grazioli ◽  
Pietro Casarin

Acute hepatitis A is generally a self-limited disease in healthy subjects within few weeks, but an uncommon type of prolonged and biphasic acute course of hepatitis A infection has been also described. This type of presentation is observed in about 6-10% of patients, but a small number of reports, concerning this topic, are available in literature. In addition hepatitis A virus (HAV) infection in hepatitis B virus (HBV) carriers has rarely been discussed. A 41-year-old Italian man, already known to our Department for HBV infection as an inactive carrier HBsAg(+)ve, experienced a prolonged and biphasic course of acute hepatitis A, lasting about 7 months. In this patient possible factors, causing the second flare of transaminases, were excluded (in particular autoimmunity). Liver biopsy as well HAV RNA search in blood/stools were not performed. In conclusion, the hepatologist should take into account this type of atypical course in patients with HAV-related hepatitis and should promote HAV vaccination in subjects with HBV-chronic hepatitis, to prevent possible life-threatening acute exacerbation of hepatic damage, mainly in HBV-carriers with more severe forms of liver diseases.


2017 ◽  
Vol 112 ◽  
pp. S1569-S1570
Author(s):  
Babusai Rapaka ◽  
Rushikesh Shah ◽  
Sonali Sakaria

Hepatology ◽  
1994 ◽  
Vol 19 (4) ◽  
pp. 857-865 ◽  
Author(s):  
Detlef Jakschies ◽  
Reinhardt Zachoval ◽  
Rainer Müller ◽  
Michael Manns ◽  
Klaus-Ulrich Nolte ◽  
...  

Hepatology ◽  
1984 ◽  
Vol 4 (3) ◽  
pp. 504-509 ◽  
Author(s):  
Kwesi N. Tsiquaye ◽  
Tim J. Harrison ◽  
Bernard Portmann ◽  
Shanlian Hu ◽  
Arie J. Zuckerman

Sign in / Sign up

Export Citation Format

Share Document